Fibrinolytic inhibitors in cardiac surgery - a view from the end of the first decade of the new millennium

[1]  J. Murkin.  Lessons Learned in Antifibrinolytic Therapy: The BART Trial , 2009, Seminars in cardiothoracic and vascular anesthesia.

[2]  M. Ranucci,et al.  Living without aprotinin: the results of a 5‐year blood saving program in cardiac surgery , 2009, Acta anaesthesiologica Scandinavica.

[3]  W. Dietrich.  Aprotinin: 1 year on , 2009, Current opinion in anaesthesiology.

[4]  A. Laupacis,et al.  The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis , 2009, Canadian Medical Association Journal.

[5]  Du Feng,et al.  The use of antifibrinolytic agents in spine surgery. A meta-analysis. , 2008, The Journal of bone and joint surgery. American volume.

[6]  R. Martineau,et al.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. , 2008, The New England journal of medicine.

[7]  P. Wouters,et al.  Aprotinin reduces cardiac troponin I release and inhibits apoptosis of polymorphonuclear cells during off-pump coronary artery bypass surgery. , 2008, Journal of cardiothoracic and vascular anesthesia.

[8]  M. Malý,et al.  Fibrinolysis in coronary artery surgery: detection by thromboelastography. , 2007, Interactive cardiovascular and thoracic surgery.

[9]  H. Groen,et al.  Efficacy and Safety of Antifibrinolytic Drugs in Liver Transplantation: A Systematic Review and Meta‐Analysis , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  Z. Straka,et al.  Aprotinin reduces troponin I levels in OPCABG. , 2006, The Annals of thoracic surgery.

[11]  G. Angelini,et al.  A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. , 2006, The Journal of thoracic and cardiovascular surgery.

[12]  Keyvan Karkouti,et al.  A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.

[13]  F. Sellke,et al.  Aprotinin in cardiac surgery , 2006, Expert review of cardiovascular therapy.

[14]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[15]  B. Griffith,et al.  Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. , 2006, The Annals of thoracic surgery.

[16]  Z. Straka,et al.  Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  J. Dunning,et al.  Does prophylactic tranexamic acid safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac surgery? , 2004, Interactive cardiovascular and thoracic surgery.

[18]  O. Alfieri,et al.  Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. , 2004, The Journal of thoracic and cardiovascular surgery.

[19]  S. Westaby.  Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit , 2004, Intensive Care Medicine.

[20]  J. Levy.  Pharmacologic preservation of the hemostatic system during cardiac surgery. , 2001, The Annals of thoracic surgery.

[21]  M. Prins,et al.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.

[22]  B. Chaitman,et al.  Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. , 1998, The Journal of thoracic and cardiovascular surgery.

[23]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.